loading page

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
  • +1
  • Takayoshi Suga,
  • Yuko Kimura,
  • Kensuke Furuya,
  • Hiroko Sato
Takayoshi Suga
Shibukawa Iryo Center

Corresponding Author:[email protected]

Author Profile
Yuko Kimura
Shibukawa Iryo Center
Author Profile
Kensuke Furuya
Shibukawa Iryo Center
Author Profile
Hiroko Sato
Shibukawa Iryo Center
Author Profile

Abstract

Hepatocellular carcinoma concurent with gastric adenocarcinoma is a rare but possible case. In addition, selecting an effective treatment for two primary cancers is often difficult. In this report, we present the first case of hepatocellular carcinoma concurent with gastric adenocarcinoma treated with atezolizumab and bevacizumab combination therapy.
14 Jun 2023Submitted to Clinical Case Reports
20 Jun 2023Submission Checks Completed
20 Jun 2023Assigned to Editor
26 Jun 2023Reviewer(s) Assigned
21 Jul 2023Review(s) Completed, Editorial Evaluation Pending
19 Aug 2023Editorial Decision: Accept